PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 12, 2026Nutritional Neuroscience0 citations

Neuroprotective role of phenolic acids: mechanistic insights into cognitive decline and neurodegenerative disorder

View Full Paper
KPKunal Balwant PatilSSSinoy SugunanAPAnirudh Padiyar

Key Points

  • This review aims to evaluate the neuroprotective mechanisms of phenolic acids and their efficacy against cognitive decline and neurodegeneration.
  • Conducted a narrative literature review using recent experimental, clinical, and epidemiological studies.
  • Focused on significant phenolic acids such as caffeic and chlorogenic acids in relation to Alzheimer’s and Parkinson’s diseases.
  • Evaluated both molecular mechanisms and dietary implications for cognitive functions.
  • Preclinical studies reveal that phenolic acids exhibit antioxidant and anti-inflammatory effects through pathways like Nrf2/HO-1 and NF-κB.
  • Human studies show that increased dietary intake of phenolic acids correlates with improved cognitive performance and lower cognitive decline risk.
  • Phenolic acids protect dopaminergic neurons and reduce amyloid-beta and α-synuclein toxicity.

Abstract

BACKGROUND: Age-associated cognitive deterioration and neurodegenerative conditions, including Alzheimer's disease (AD) and Parkinson's disease (PD), are predominantly influenced by oxidative stress, neuroinflammation, mitochondrial dysfunction, and abnormal protein aggregation. Dietary phenolic acids, prevalent in plant-based foods, have demonstrated potential neuroprotective and cognitive-enhancing effects in recent studies. PURPOSE: This review seeks to thoroughly assess the neuroprotective mechanisms of phenolic acids and to consolidate existing evidence from human and preclinical studies concerning their potential efficacy in alleviating cognitive impairment and neurodegeneration. STUDY DESIGN: Narrative and evidence-based literature review. METHODS: Recent experimental, clinical, and epidemiological studies examining significant phenolic acids - such as caffeic, chlorogenic, ferulic, gallic, rosmarinic, sinapic, ellagic, protocatechuic, p-coumaric, and tannic acids - in relation to AD, PD, and cognitive functions were retrieved from electronic databases. We put together the most important information about molecular mechanisms and treatment. RESULTS: Preclinical studies show that phenolic acids have antioxidant, anti-inflammatory, anti-apoptotic, and anti-aggregation effects by changing important signaling pathways like Nrf2/HO-1, NF-κB, and PI3 K/Akt. These actions protect dopaminergic neurons, lower the toxicity of amyloid-beta and α-synuclein, and make behavior better in disease models. Human studies suggest that increased dietary consumption of phenolic acids, especially hydroxycinnamic acids such as caffeic and chlorogenic acid, is associated with enhanced cognitive performance and a diminished risk of cognitive decline, although results are not uniform. CONCLUSION: Phenolic acids are secure, readily accessible neuroprotective compounds that can alter various pathological pathways associated with cognitive decline and the progression of neurodegenerative diseases.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Patil et al. (2026) studied this question.

synapsesocial.com/papers/6a02c2b9ce8c8c81e96403fbhttps://doi.org/10.1080/1028415x.2026.2669234
Ask AI
Helpful
Bookmark
Share
View Full Paper